Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 August 2025 | Story Precious Shamase | Photo Teboho Mositi
From the left: Dr Grey Magaiza, Deputy Director of CGAS; Prof Vasu Reddy, Deputy Vice-Chancellor: Research and Internationalisation; Prof Cias Tsotetsi, Campus Vice-Principal: Academic and Research; and Prof Jared McDonald, Assistant Dean of the Faculty of The Humanities.

The Centre for Gender and Africa Studies (CGAS) on the University of the Free State (UFS) Qwaqwa Campus recently hosted the Biennial Gendered Worlds Lecture. The series focuses on the meaning and interpretation of the social, cultural, and political environments where gender is constructed, experienced, and contested. The recent lecture featured a captivating address by Prof Vasu Reddy, the Deputy Vice-Chancellor: Research and Internationalisation. Titled The Taste(s) of Intimacies: Reflections on the Trifecta of Food, Sexuality and Love in Gendered Worlds, this lecture invited the audience to explore the complex, interconnected nature of these three domains.

Prof Reddy opened his talk by describing food, sexuality, and love as ‘grammars of intimacy’ – a powerful metaphor suggesting that these elements encode cultural scripts, regulate bodies, and create opportunities for resistance and transformation. He intentionally used the term ‘trifecta’, borrowed from horse racing, to highlight the synergistic yet sometimes incompatible relationship between these three elements. He explained that this trifecta provides a profound framework for understanding how intimacy is experienced, negotiated, and theorised within different cultural and gendered contexts.

The lecture was structured in several parts, beginning with a personal reflection on Prof Reddy’s upbringing. He shared an intimate image of himself and his grandmother, explaining how her kitchen was not just a domestic space for cooking and nurturing. He motivated that his grandmother’s kitchen was a site of ‘gendered and feminist pedagogy’. He described it as a space not just for nourishment, but also for learning. This is where he learned about nurturing and care through observation and storytelling. This personal anecdote set the stage for a broader discussion on the socio-political dimensions of food, which he described as a ‘mode of enquiry and practice’ and an ‘object of power’. He noted that food preparation is a form of gendered labour and highlighted how apartheid structured food along racial lines, turning dishes such as ‘chakalaka’ from symbols of struggle and survival into commodified examples for elite consumption.

Moving on to sexuality, Prof Reddy argued that, like food, it is a domain where intimacy meets regulation. He referenced the work of Zanele Muholi, a renowned visual activist, whose photography in projects such as Somnyama Ngonyama (‘Hail the dark lioness’) confronts histories of colonialism and gendered violence by asserting the visibility and dignity of black and queer bodies. This aspect of the lecture emphasised how sexuality is not merely personal but is deeply shaped by cultural and political scripts.

In another component of this lecture, Prof Reddy delved into the complex nature of love. He proposed that love, though often idealised as apolitical, is deeply structured by cultural norms and power relations. Drawing on the work of scholar Sara Ahmed, he described love as a ‘sticky emotion’ that adheres to certain bodies and relationships, shaping how people are nourished, touched, and recognised. He highlighted that love is often a struggle – a messy, unpredictable, and transformative process.

Prof Reddy also discussed the ‘affective dimension’ of these matters, explaining that emotions are not just personal feelings, but social forces that shape bodies, spaces, and politics. He linked this to the concept of ‘taste’, suggesting that it is not only a sensory experience, but also an affective one, laden with social context, pleasure, and sometimes shame.

Throughout the lecture, Prof Reddy emphasised the entanglement of the private and public realms, asserting that intimacy is not confined to the bedroom but is shaped by public politics and collective norms. He concluded by presenting resistance and liberation as central to the discussion, positing that food, sexuality, and love can be sites of radical acts. He cited bell hooks, who argued that intimacy can be a powerful force for healing and self-definition in the face of systemic oppression.

For Prof Reddy, gendered worlds are not just sites of oppression, but also spaces of possibility that prompt further questions to make sense of ourselves.

In his closing remarks, he invited the audience to consider the profound questions his lecture posed: What does intimacy taste like? Who gets to taste it? And how is that taste shaped by gender, power, and history? He encouraged everyone to critically engage with these questions – not just intellectually, but personally – to reimagine intimacy as a public, relational, and transformative practice for building a more equitable world.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept